Raymond J. March | Tuesday August 7, 2018 at 1:39 PM PDT
Off-label information policy reform works to broaden what information drug providers can share.
You can now support the Independent Institute when you shop on Amazon with the AmazonSmile program. Every time you make a purchase, 0.5% will be donated to Independent on your behalf, at no extra cost to you. Just visit smile.amazon.com, log in using your usual Amazon account details, and select the Independent Institute as your charity.New Books
Free Shipping On Orders Over $60! (Within U.S.A.)
Tag: pharmaceutical regulations
John R. Graham | Tuesday October 4, 2016 at 5:01 PM PDT
The Goldwater Institute has had great success getting states to pass “Right to Try” laws. Right to Try allows a desperately sick patient to take an experimental new medicine before the FDA has approved it. Since I last wrote about this in May 2014, 31 states have passed Right to Try. Further, U.S. Senator […]
John R. Graham | Wednesday October 7, 2015 at 5:00 AM PDT
BloombergBusiness has another story of a jaw-dropping price hike for a very old medical. In this case, Colchicine, a gout remedy so old that the ancient Greeks knew about its effects, used to cost about 25 cents per pill in the U.S. Then in 2010 its price suddenly jumped 2,000 percent. How did this […]
